Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Freeman

Showing results (131-140 of 209) with videos related to

Pageof 21
Sort By:
Pain|September 7, 2021
Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber functionSunil M Jain, Ramanathan Balamurugan, Monika Tandon, et al.
Diabetes|October 7, 2015
Baroreflex Sensitivity Impairment During Hypoglycemia: Implications for Cardiovascular ControlAjay D Rao, Istvan Bonyhay, Joel Dankwa, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|September 21, 2023
Effect of hypoglycemia on baroreflex sensitivity in individuals with type 2 diabetes: implications for autonomic control of cardiovascular function in diabetesAndrea V Haas, Andrew Koefoed, Rebecca M Easly, et al.
Endocrine Connections|November 17, 2021
Effect of adrenocorticotropic hormone infusion on circulating sclerostin levelsSarah Zaheer, Kayla Meyer, Rebecca Easly, et al.
Neurology|June 20, 2014
Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trialHoracio Kaufmann, Roy Freeman, Italo Biaggioni, et al.
Hypertension (Dallas, Tex. : 1979)|November 21, 2024
Cerebral Blood Flow Dynamics in Neurogenic Orthostatic Hypotension: A Systematic Review and Meta-AnalysisJacquie R Baker, Paul A Beach, Shaun I Ranada, et al.
Annals of Clinical and Translational Neurology|August 10, 2022
Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stagesRoy Freeman, Alejandra Gonzalez-Duarte, Fabio Barroso, et al.
Diabetes Care|December 22, 2016
Diabetic Neuropathy: A Position Statement by the American Diabetes AssociationRodica Pop-Busui, Andrew J M Boulton, Eva L Feldman, et al.
Journal of the Peripheral Nervous System : JPNS|January 11, 2019
Peripheral Neuropathy Research Registry: A prospective cohortSimone Thomas, Senda Ajroud-Driss, Mazen M Dimachkie, et al.
Pain Medicine (Malden, Mass.)|September 8, 2020
Reliability and Validity of the Boston Bedside Quantitative Sensory Testing Battery for Neuropathic PainAlexandra E Koulouris, Robert R Edwards, Kathleen Dorado, et al.
Pageof 21

Showing results (131-140 of 209) with videos related to

Sort By:
Pageof 21
Pain|September 7, 2021
Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber functionSunil M Jain, Ramanathan Balamurugan, Monika Tandon, et al.
Diabetes|October 7, 2015
Baroreflex Sensitivity Impairment During Hypoglycemia: Implications for Cardiovascular ControlAjay D Rao, Istvan Bonyhay, Joel Dankwa, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|September 21, 2023
Effect of hypoglycemia on baroreflex sensitivity in individuals with type 2 diabetes: implications for autonomic control of cardiovascular function in diabetesAndrea V Haas, Andrew Koefoed, Rebecca M Easly, et al.
Endocrine Connections|November 17, 2021
Effect of adrenocorticotropic hormone infusion on circulating sclerostin levelsSarah Zaheer, Kayla Meyer, Rebecca Easly, et al.
Neurology|June 20, 2014
Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trialHoracio Kaufmann, Roy Freeman, Italo Biaggioni, et al.
Hypertension (Dallas, Tex. : 1979)|November 21, 2024
Cerebral Blood Flow Dynamics in Neurogenic Orthostatic Hypotension: A Systematic Review and Meta-AnalysisJacquie R Baker, Paul A Beach, Shaun I Ranada, et al.
Annals of Clinical and Translational Neurology|August 10, 2022
Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stagesRoy Freeman, Alejandra Gonzalez-Duarte, Fabio Barroso, et al.
Diabetes Care|December 22, 2016
Diabetic Neuropathy: A Position Statement by the American Diabetes AssociationRodica Pop-Busui, Andrew J M Boulton, Eva L Feldman, et al.
Journal of the Peripheral Nervous System : JPNS|January 11, 2019
Peripheral Neuropathy Research Registry: A prospective cohortSimone Thomas, Senda Ajroud-Driss, Mazen M Dimachkie, et al.
Pain Medicine (Malden, Mass.)|September 8, 2020
Reliability and Validity of the Boston Bedside Quantitative Sensory Testing Battery for Neuropathic PainAlexandra E Koulouris, Robert R Edwards, Kathleen Dorado, et al.
Pageof 21